$1.77M award gives Temple researchers chance to investigate therapy for cocaine addiction

(Temple University Health System) Researchers at the Lewis Katz School of Medicine at Temple University have received a new $1.77M grant from the National Institute on Drug Abuse that will allow them to explore whether a drug called clavulanic acid can help patients recover from cocaine use disorder. Clavulanic acid is part of an existing therapy known as Augmentin. Augmentin combines clavulanic acid with the penicillin-related antibiotic amoxicillin and is used for the treatment of bacterial infections.
Source: EurekAlert! - Social and Behavioral Science - Category: International Medicine & Public Health Source Type: news